Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces the results of the voting by shareholders at the Annual General Meeting (“AGM”) which took place on June 2, 2016, in Marseille, France. All resolutions were voted in accordance with the management’s recommendations.
Total of 24,290,258 votes were cast out of a total of 53,877,079 shares with voting rights, representing a quorum of 45.084%.
Details of the votes are available on the Company’s website, in the investors’ room
The 2015 Activity Report and the 2015 Reference Document of the Company are available on its website.
| PR in English | 69.71 KB |
| CP en français | 30.11 KB |